Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Man-Fung Yuen

Showing results (81-90 of 529) with videos related to

Pageof 53
Sort By:
European Journal of Gastroenterology & Hepatology|July 13, 2007
Etiologies of chronic liver diseases in Hong KongKonrad Tang-Tat Fung, James Fung, Ching-Lung Lai, et al.
Expert Opinion on Drug Safety|January 12, 2016
DNA polymerase inhibitors for treating hepatitis B: a safety evaluationLung-Yi Mak, Wai-Kay Seto, Ching-Lung Lai, et al.
The Lancet. Infectious Diseases|March 28, 2009
Prevention and management of drug resistance for antihepatitis B treatmentMan-Fung Yuen, James Fung, Danny Ka-Ho Wong, et al.
Journal of Clinical Gastroenterology|August 13, 2002
Acute hepatitis as a presentation of acute appendicitis in an immunocompromised patientChi-Keung Yeung, Man-Fung Yuen, Ching-Lung Lai, et al.
Hepatobiliary Surgery and Nutrition|February 27, 2014
Do statins reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis B?James Fung, Ching-Lung Lai, Man-Fung Yuen, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 3, 2018
An update on the toxicological considerations for protease inhibitors used for hepatitis C infectionLung-Yi Mak, Wai-Kay Seto, Ching-Lung Lai, et al.
Journal of Ethnopharmacology|October 24, 2015
Berberine and Coptidis Rhizoma as potential anticancer agents: Recent updates and future perspectivesNing Wang, Hor-Yue Tan, Lei Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2013
Reply to Liao et alWai-Kay Seto, Danny Ka-Ho Wong, Ching-Lung Lai, et al.
Clinics in Liver Disease|October 1, 2023
Novel Drug Development in Chronic Hepatitis B Infection: Capsid Assembly Modulators and Nucleic Acid PolymersLung-Yi Mak, Rex Wan-Hin Hui, Wai-Kay Seto, et al.
Expert Review of Gastroenterology & Hepatology|January 23, 2016
Hepatitis B: treatment choice and monitoring for response and resistanceSze-Hang Kevin Liu, Wai-Kay Seto, Ching-Lung Lai, et al.
Pageof 53

Showing results (81-90 of 529) with videos related to

Sort By:
Pageof 53
European Journal of Gastroenterology & Hepatology|July 13, 2007
Etiologies of chronic liver diseases in Hong KongKonrad Tang-Tat Fung, James Fung, Ching-Lung Lai, et al.
Expert Opinion on Drug Safety|January 12, 2016
DNA polymerase inhibitors for treating hepatitis B: a safety evaluationLung-Yi Mak, Wai-Kay Seto, Ching-Lung Lai, et al.
The Lancet. Infectious Diseases|March 28, 2009
Prevention and management of drug resistance for antihepatitis B treatmentMan-Fung Yuen, James Fung, Danny Ka-Ho Wong, et al.
Journal of Clinical Gastroenterology|August 13, 2002
Acute hepatitis as a presentation of acute appendicitis in an immunocompromised patientChi-Keung Yeung, Man-Fung Yuen, Ching-Lung Lai, et al.
Hepatobiliary Surgery and Nutrition|February 27, 2014
Do statins reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis B?James Fung, Ching-Lung Lai, Man-Fung Yuen, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 3, 2018
An update on the toxicological considerations for protease inhibitors used for hepatitis C infectionLung-Yi Mak, Wai-Kay Seto, Ching-Lung Lai, et al.
Journal of Ethnopharmacology|October 24, 2015
Berberine and Coptidis Rhizoma as potential anticancer agents: Recent updates and future perspectivesNing Wang, Hor-Yue Tan, Lei Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2013
Reply to Liao et alWai-Kay Seto, Danny Ka-Ho Wong, Ching-Lung Lai, et al.
Clinics in Liver Disease|October 1, 2023
Novel Drug Development in Chronic Hepatitis B Infection: Capsid Assembly Modulators and Nucleic Acid PolymersLung-Yi Mak, Rex Wan-Hin Hui, Wai-Kay Seto, et al.
Expert Review of Gastroenterology & Hepatology|January 23, 2016
Hepatitis B: treatment choice and monitoring for response and resistanceSze-Hang Kevin Liu, Wai-Kay Seto, Ching-Lung Lai, et al.
Pageof 53